ResMed RMD Rest of the World — Net revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: ResMed’s 10-K, filed August 8, 2025, on SEC EDGAR. View the filing →
Ask your AI about ResMed's rest of the world — net revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ResMed's rest of the world — net revenue?
- ResMed (RMD) reported rest of the world — net revenue of $465.19M in Q2 2025.
- How has ResMed's rest of the world — net revenue changed year-over-year?
- ResMed's rest of the world — net revenue increased by 9.1% year-over-year, from $426.31M to $465.19M.
- What is the long-term trend for ResMed's rest of the world — net revenue?
- Over 3 years (2022 to 2025), ResMed's rest of the world — net revenue has grown at a 11.9% compound annual growth rate (CAGR), from $1.33B to $1.86B.
- What does rest of the world — net revenue mean?
- This metric represents the total revenue generated from sales of medical devices, masks, and accessories within geographic regions outside of the company's primary domestic market. It reflects the company's ability to capture market share and drive adoption of respiratory care solutions in international territories. Growth in this metric indicates successful expansion of distribution networks and increasing global penetration of sleep apnea treatment products.